REFERENCES
- Earle C, Keogh E, Wisniewski Z. et al. Prostaglandin E1 therapy for impotence, comparison with papaverine. J Urol 1990; 143: 57.
- Gerber G, Levine L. Pharmacological erection program using prostaglandin E1. J Urol 1991; 146: 786–789.
- Girdley F, Bruskewitz R, Feyzi J, Graversen P, Gasser T. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. J Urol 1988: 140: 972.
- Golub M, Zia P, Matsuno M, Horton R. Metabolism of prostaglandins A1 and E1 in man. J Clin Invest 1975; 59: 1404.
- Ishii N, Watanabe H, Irisawa C, et al, Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence. J Urol 1989; 141: 323–325.
- Lee L, Stevenson R, Szacz G. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J Urol 1989; 141: 549.
- Levine S, Althof S, Turner L, et al. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J Urol 1989; 141: 54.
- Lundberg L, Olsson J-O, Kihl B. Long-term experience of self-injection therapy with prostaglandin E1 for erectile dysfunction. Abstract submitted to Scand J Urol Nephrol.
- Moriel EZ, Rajfer J. Sodium bicarbonate alleviates pain induced by intracavernous injections for erectile dysfunction. J Urol 1993; 149: 1299–1300.
- Olsson J-O, Kihl B. Self-injection therapy with prostaglandin E1 for erectile dysfunction. Scand J Urol Nephrol 1992; (Suppl 144): 8.
- Schramek P, Dorninger R, Waldhauser M, Konecny P, Porpaczy P. Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism. Br J Urol 1990; 65: 68–71.
- Stackl W, Hasun R, Marberger M. Intracavernous injection of prostaglandin E1 in impotent men. J Urol 1988; 140: 66–68.
- Waldhauser M. Schramek P. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. J Urol 1988: 140: 525.
- Watters G, Keogh E, Earle C, Wisniewski Z, Tulloch A, Lord D. Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs. J Urol 1988; 140: 1417.